Technical Analysis for BMSN - Bio-Matrix Scientific Group Inc

Grade Last Price % Change Price Change
grade C 0.0001 0.00% 0.0000
BMSN closed unchanged on Monday, October 14, 2019, on 51 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Extremely Strong Flat Flat Flat
See historical BMSN trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Below Lower BB Weakness 0.00%

Older signals for BMSN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bio-Matrix Scientific Group, Inc., through its subsidiary, Regen BioPharma, Inc., is engaged in the development of regenerative medical applications. The Company focuses on licensing from other entities up to the point of successful completion of Phase I and or Phase II clinical trials, after which it intends to sell or license those developed applications or advance the application further to Phase III clinical trials. Its products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax and Small Molecules. The Company is focused on the development of HemaXellerate I, a cellular therapy designed to heal damaged bone marrow. HemaXellerate II is intended to be a universal donor endothelial cell-based therapeutic. dCellVax is intended to be a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is intended to be an autologous cellular product. The Company identifies small molecules via a high throughput screening program.
Biotechnology Cancer Nature Biology Stem Cells Cell Biology Cell Therapy Regenerative Biomedicine Stem Cell Therapy Biomedical Engineering Bone Marrow
Is BMSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0003
52 Week Low 0.0001
Average Volume 982,603
200-Day Moving Average 0.0001
50-Day Moving Average 0.0001
20-Day Moving Average 0.0001
10-Day Moving Average 0.0001
Average True Range 0.0001
ADX 99.94
+DI 71.4286
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) -0.0002
Chandelier Exit (Short, 3 ATRs ) 0.0004
Upper Bollinger Band 0.0001
Lower Bollinger Band 0.0001
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0001
Resistance 3 (R3) 0.0001 0.0001 0.0001
Resistance 2 (R2) 0.0001 0.0001 0.0001 0.0001
Resistance 1 (R1) 0.0001 0.0001 0.0001 0.0001 0.0001
Pivot Point 0.0001 0.0001 0.0001 0.0001 0.0001
Support 1 (S1) 0.0001 0.0001 0.0001 0.0001 0.0001
Support 2 (S2) 0.0001 0.0001 0.0001 0.0001
Support 3 (S3) 0.0001 0.0001 0.0001
Support 4 (S4) 0.0001